Amplify Weight Loss Drug & Treatment ETF (THNR) Institutional Ownership $22.76 -0.48 (-2.07%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatings Institutional Ownership Changes (13F Filings) for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$251.41KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$178.38K Get THNR Insider Trade Alerts Want to know when executives and insiders are buying or selling Amplify Weight Loss Drug & Treatment ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Amplify Weight Loss Drug & Treatment ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC14,553$390K0.0%-31.4%0.000% 11/5/2024 Harbour Investments Inc.9,563$256K0.0%+43.4%0.000% 7/26/2024 Harbour Investments Inc.6,668$174K0.0%N/A0.000% (Data available from 1/1/2016 forward) THNR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THNR shares? During the previous two years, the following institutional investors and hedge funds held shares of Amplify Weight Loss Drug & Treatment ETF shares: Jane Street Group LLC ($390K), Harbour Investments Inc. ($256K).Learn more on THNR's institutional investors. Which institutional investors have been buying Amplify Weight Loss Drug & Treatment ETF stock? The following institutional investors have purchased Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: Harbour Investments Inc. ($9.56K). How much institutional buying is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have bought a total of 9,563 shares in the last 24 months. This purchase volume represents approximately $251.41K in transactions. Which Amplify Weight Loss Drug & Treatment ETF major shareholders have been selling company stock? The following institutional investors have sold Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: Jane Street Group LLC ($6.66K). How much institutional selling is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have sold a total of 6,656 shares in the last 24 months. This volume of shares sold represents approximately $178.38K in transactions. Related Companies First Trust S-Network Streaming and Gaming ETF Institutional Ownership Veridien Climate Action ETF Institutional Ownership iShares Neuroscience and Healthcare ETF Institutional Ownership Global X AgTech & Food Innovation ETF Institutional Ownership First Trust Indxx Metaverse ETF Institutional Ownership Cboe Vest 10 Year Interest Rate Hedge ETF Institutional Ownership NYLI Clean Oceans ETF Institutional Ownership AGF Global Infrastructure ETF Institutional Ownership Avantis Inflation Focused Equity ETF Institutional Ownership AdvisorShares Restaurant ETF Institutional Ownership This page (NYSEARCA:THNR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THNR Stock Alerts